Sectors
Google Ventures-backed digital coupon marketplace raises $191m in IPO on Nasdaq, with an initial market capitalisation of approximately $1.05bn.
Bluebird Bio, a clinical-stage biotechnology company, raises $116.1m on Nasdaq.
PTC Therapeutics, a US-based drugs developer for muscles, raises $144.4m on Nasdaq.
Samsung and Intel-backed YuMe has filed plans to raise $65m in an IPO.
Google Ventures-backed digital coupon marketplace files for $230m IPO on Nasdaq.
Investment bank Kempen is sole global coordinator for the initial public offering (IPO) after Cardio3 tried unsuccessfully to float in 2011.
Biogen Idec-backed Portola Pharmaceuticals raises $122m on Nasdaq.
SAP and Time Warner-backed video advertising company files for IPO.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
